Related Experiment Video
Updated: Jun 29, 2025

In Vivo Assessment of Alveolar Macrophage Efferocytosis Following Ozone Exposure
Published on: October 22, 2019
A complex immune communication between eicosanoids and pulmonary macrophages.
Erwan Pernet1, Jeremie Poschmann2, Maziar Divangahi3
1Department of Medical Biology, Université du Québec à Trois-Rivières, Québec, Canada.
This review highlights the crucial role of pulmonary macrophages and eicosanoids in the immune response to respiratory viral infections. Understanding these interactions may lead to new immunotherapies for viral diseases.
Area of Science:
- Immunology
- Pulmonary Medicine
- Virology
Background:
- Respiratory viral infections pose a significant global health challenge, necessitating deeper insights into host defense mechanisms.
- Pulmonary macrophages are key orchestrators of the lung's immune response during infection, influencing both protective and detrimental outcomes.
- Eicosanoids, bioactive lipid mediators, are increasingly recognized for their regulatory roles in pulmonary immunity.
Purpose of the Study:
- To review current knowledge on the interplay between eicosanoids and pulmonary macrophages in the context of respiratory viral infections.
- To elucidate the homeostatic and antimicrobial functions regulated by eicosanoids within the lung.
- To explore the potential of eicosanoids as therapeutic targets for managing viral respiratory diseases.
Main Methods:
- Literature review synthesizing existing research on eicosanoids, pulmonary macrophages, and viral infections.
- Analysis of studies investigating the molecular and cellular mechanisms of eicosanoid action in the lung.
- Discussion of translational research linking eicosanoid pathways to clinical outcomes in viral respiratory infections.
Main Results:
- Eicosanoids modulate diverse functions of pulmonary macrophages, including their recruitment, activation, and phagocytic capacity.
- Specific eicosanoid pathways are implicated in balancing protective immunity and excessive inflammation during viral lung infections.
- Dysregulation of eicosanoid metabolism is associated with increased disease severity in respiratory viral infections.
Conclusions:
- Eicosanoids and pulmonary macrophages are critical components of the host defense against respiratory viruses.
- Targeting eicosanoid pathways presents a promising strategy for developing novel immunotherapies to combat viral respiratory infections.
- Further research into eicosanoid signaling in the lung immunity is warranted to optimize therapeutic interventions.
More Related Videos
09:00Characterization of Immune Cells and Proinflammatory Mediators in the Pulmonary Environment
Published on: June 24, 2020
10:39Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy
Published on: April 16, 2019
Related Concept Videos
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation